Benzinga | Aug 17, 2021 09:13AM EDT

AIM ImmunoTech Q2 EPS $(0.12) Misses $(0.08) Estimate, Sales $23.00K Miss $350.00K Estimate

AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.08) by 50 percent. This is a 9.09 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $23.00 thousand which missed the analyst consensus estimate of $350.00 thousand by 93.43 percent. This is a 42.50 percent decrease over sales of $40.00 thousand the same period last year.